COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,441 Articles (22,835 medRxiv, 8,606 bioRxiv)

Most recent first Previous |  Page 991: Articles 9901-9910  | Next

Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
Shi, W., Wang, L., Zhou, T., Sastry, M., Yang, E. S., Zhang, Y., Chen, M., Chen, X., Choe, M., Creanga, A., Leung, K., Olia, A. S., Pegu, A., Rawi, R., Shen, C.-H., Stancofski, E.-S. D., Talana, C. A., Teng, I.-T., Wang, S., Corbett, K. S., Tsybovsky, Y., Mascola, J. R., Kwong, P. D.
10.1101/2022.01.25.477770 — Posted: 2022-01-26
Anti-SARS-CoV-2 swine glyco-humanized polyclonal antibody XAV-19 retains neutralizing activity against SARS-CoV-2 B.1.1.529 (Omicron)
Vanhove, B., Marot, S. S., Evanno, G., Mallet, I., Rouvray, G., Shneiker, F., Mevel, E., Ciron, C., Rousse, J., Royer, P.-J., Lheriteau, E., Raffi, F., Duvaux, O., Marcelin, A.-G., Calvez, V.
10.1101/2022.01.26.477856 — Posted: 2022-01-26
Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19
Unoh, Y., Uehara, S., Nakahara, K., Nobori, H., Yamatsu, Y., Yamamoto, S., Maruyama, Y., Taoda, Y., Kasamatsu, K., Suto, T., Kouki, K., Nakahashi, A., Kawashima, S., Sanaki, T., Toba, S., Uemura, K., Mizutare, T., Ando, S., Sasaki, M., Orba, Y., Sawa, H., Sato, A., Sato, T., Kato, T., Tachibana, Y.
10.1101/2022.01.26.477782 — Posted: 2022-01-26
Cytotoxic T lymphocytes targeting a conserved SARS-CoV-2 spike epitope are efficient serial killers
Fathi, M., Charley, L., Cooper, L. J. N., Varadarajan, N., Meyer, D.
10.1101/2022.01.24.477535 — Posted: 2022-01-26
Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecoviruses
Mao, T., Goldman-Israelow, B., Suberi, A., Zhou, L., reschke, m., pena-hernandez, M., Dong, H., Homer, R., Saltzman, M., Iwasaki, A.
10.1101/2022.01.24.477597 — Posted: 2022-01-26
Adverse events following COVISHIELD (ChAdOx1nCoV-19) vaccination among health care workers in Sri Lanka; a multi-centre cross sectional survey
Manilgama, S. R., Hettiarachchi, N. M., Jayasinghe, I. K., De Silva, S. T., Jayalath, T., Wanigaratne, T., Rathnayake, B. P., Suganthan, N., Sudarshan, P., Pathirage, M., Rajaratnam, N., Senaratne, G., Rajapaksha, V., Wickramasinghe, A., Ranaweera, S. P. A. L., Thilakarathna, A. H. M., Kulaweera, M. T. D.
10.1101/2022.01.26.22269788 — Posted: 2022-01-26
Comparison of vaccine effectiveness against the Omicron (B.1.1.529) variant in patients receiving haemodialysis
Spensley, K., Gleeson, S., Martin, P., Thomson, T., Clarke, C. L., Pickard, G., Thomas, D. C., McAdoo, S. P., Randell, P., Kelleher, P., Bedi, R., Lightstone, L., Prendecki, M., Willicombe, M.
10.1101/2022.01.25.22269804 — Posted: 2022-01-26
Comparative immunogenicity of heterologous versus homologous 3rd SARS-CoV-2 vaccine doses in kidney transplant recipients
Thomson, T., Prendecki, M., Gleeson, S., Martin, P., Spensley, K., Seneschall, C., Gan, J., Clarke, C. L., Lewis, S., Pickard, G., Thomas, D. C., McAdoo, S. P., Lightstone, L., Cox, A., Kelleher, P., Willicombe, M.
10.1101/2022.01.25.22269778 — Posted: 2022-01-26 Discussion: Offsite
Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
Servellita, V., Syed, A. M., Brazer, N., Saldhi, P., Garcia-Knight, M., Sreekumar, B., Khalid, M. M., Ciling, A., Chen, P.-Y., Kumar, G. R., Gliwa, A. S., Nguyen, J., Sotomayor-Gonzalez, A., Zhang, Y., Frias, E., Prostko, J., Hackett, J., Andino, R., Doudna, J., Ott, M., Chiu, C. Y.
10.1101/2022.01.25.22269794 — Posted: 2022-01-26
Predictive and analysis of COVID-19 cases cumulative total：ARIMA model based on machine learning
Yan, Z., Wang, Y., Yang, M., Li, Z., Gong, X., Wu, D., Wang, Y.
10.1101/2022.01.24.22269791 — Posted: 2022-01-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).